FDA approves stomach-draining obesity treatment - News Summed Up

FDA approves stomach-draining obesity treatment


It's the latest in a series of new options for millions of obese Americans who have been unable to lose weight via more traditional methods. A new weight loss device offers a novel approach to cutting calories: draining them from the stomach before they are digested. The FDA says side-effects related to use of the AspireAssist include occasional indigestion, nausea, vomiting, constipation and diarrhea. The AspireAssist system consists of a thin tube implanted in the stomach, connecting to an outside port on the skin of the belly. The manufacturer says its system removes about 30 per cent of food stored in the stomach before it begins causing weight gain.


Source: CBC News June 14, 2016 20:48 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */